• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register

Istradefylline

Product ID I7478
Cas No. 155270-99-8
Purity ≥99%
Product Unit SizeCostQuantityStock
5 mg $82.60 In stock
25 mg $330.70 In stock
100 mg $985.00 In stock
Bulk Quote
Add to Wishlist

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Istradefylline is a competitive inhibitor of adenosine A2A receptors that exhibits tremorlytic activity. Istradefylline is currently under examination as a potential treatment for Parkinson’s disease, as it decreases “off” time in subjects with Parkinson’s disease without worsening dyskinesia. Istradefylline increases dopamine levels in normal and 6-OHDA-lesioned animal models, improving cognitive performance. In other animal models, istradefylline decreases GABA release and elicits conditioned place preference (CPP) and increases locomotor activity, indicating a potential role for adenosine receptors in reward and reinforcement.

Product Info

Cas No.

155270-99-8

Purity

≥99%

Formula

C20H24N4O4

Formula Wt.

384.43

Chemical Name

(E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methylxanthine

IUPAC Name

8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione

Synonym

8-[(1E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-1H-purine-2,6-dione, KW-6002

Solubility

DMSO 6 mg/mL (15.6 mM) Water Insoluble Ethanol Insoluble

Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

I7478 MSDS PDF

Info Sheet

I7478 Info Sheet PDF

References

Kadowaki Horita T, Kobayashi M, Mori A, et al. Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex. Psychopharmacology (Berl). 2013 Dec;230(3):345-52. PMID: 23748382.

Saki M, Yamada K, Koshimura E, et al. In vitro pharmacological profile of the A2A receptor antagonist istradefylline. Naunyn Schmiedebergs Arch Pharmacol. 2013 Nov;386(11):963-72. PMID: 23812646.

Mizuno Y, Hasegawa K, Kondo T, et al. Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study. Mov Disord. 2010 Jul 30;25(10):1437-43. PMID: 20629136.

Salamone JD, Betz AJ, Ishiwari K, et al. Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism. Front Biosci. 2008 May 1;13:3594-605. PMID: 18508458.

Harper LK, Beckett SR, Marsden CA, et al. Effects of the A 2A adenosine receptor antagonist KW6002 in the nucleus accumbens in vitro and in vivo. Pharmacol Biochem Behav. 2006 Jan;83(1):114-21. PMID: 16451807.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2023 LKT Laboratories, All Rights Reserved - Products for research use only